I.R.I.S.

I.R.I.S. (Institut de Recherches Internationales Servier) is the primary research and development arm of the Servier Group, a global pharmaceutical company governed by a non-profit foundation. Headquartered in Suresnes, France, I.R.I.S. is responsible for the discovery, clinical development, and regulatory submission of the group's therapeutic pipeline. The organization focuses on five key therapeutic areas: oncology, cardiovascular and metabolic diseases, immune-inflammatory diseases, and neurodegenerative diseases. I.R.I.S. manages a vast network of clinical trials worldwide and has recently strengthened its oncology portfolio through significant acquisitions and strategic partnerships. The entity plays a critical role in advancing innovative treatments from early-stage research to global market authorization.